Enzymes are attractive targets for pharmacological intervention, owing to their essential roles in life processes and pathophysiology. Because of their critical roles in the study of drug metabolism, pharmacokinetics and toxicity reactions, the demand for the new enzyme assay development is increasing. Creative BioMart is committed to developing a variety of comprehensive assays. In addition to the popular kinase and protease assay panels, Creative BioMart offers miscellaneous enzyme assay services, including but not limited to, lipases, oxidoreductases, deacetylases, CYP450 enzymes, and phosphodiesterases (PDE), all of which have been identified as prospective druggable entities.
This promotion has ended.
The winner will be announced soon.